Scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment.

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers at the Norwegian University of Science and Technology (NTNU) has now created an AI diagnostic tool that can help lighten the burden.

On World Cancer Day, the National Comprehensive Cancer Network (NCCN) pledges to update robust information resources for cancer patients and caregivers on an annual basis in both English and Spanish.

A new study published in Nature Genetics reveals that not all cancer-associated mutations in the same gene behave alike. Led in part by researchers from Koç University, the work shows that different mutations in the CTNNB1 gene drive β-catenin signalling to varying strengths, and that tumours in different tissues selectively favour specific signalling levels. In liver cancer, weaker CTNNB1 mutations are linked to greater immune cell infiltration, suggesting a higher likelihood of response to immunotherapy. These findings highlight the importance of mutation “strength,” not just mutation presence, for more precise and personalised cancer treatment strategies.

Engineering multifunctional extracellular vesicles that can selectively and effectively kill lung cancer cells with minimal off‑target toxicity, offers a promising platform for next‑generation, precision‑guided cancer therapeutics.

How this fungus influences the development of melanoma cells has for the first time been explained by the MicrobiomicsEHU group of the University of the Basque Country. The results pave the way for using antifungal therapies to complement conventional treatment to combat the most deadly skin cancer.

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.